-
News
- TcLand Expression will receive 1.2 million Euros from Oseo and ERDF to support a leading project in personalised medicine focused on Rheumatoid Arthritis
- TcLand Expression’s board of directors appoints highly qualified personalized medicine expert Felix Frueh PhD, as new board member
- TcLand Expression is part of the Innovative Medicines Initiative “Be The CURE”, the largest European consortium for Rheumatology
- TcLand Expression launches the “PRINT” international clinical trial to validate its blood biomarker RA-INF-Dx and announces the recruitment of its first patient
- TcLand Expression nominated as a featured member of the US Personalized Medicine Coalition
News categories
- Business / Finance (3)
- Corporate (4)
- R&D / Quality (7)
- Uncategorized (1)
TcLand Expression launches the “PRINT” international clinical trial to validate its blood biomarker RA-INF-Dx and announces the recruitment of its first patient
This entry was posted in R&D / Quality. Bookmark the permalink.